Pay in 4 interest-free payments of $5.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
PRINCIPIO ACTIVO: CLONIXINATO DE LISINA
en lugar seco
OHRENCIA® 250 mg es un medicamento de uso intravenoso o subcutáneo que contiene Abatacept
FORMOTEROL
KYLEENA® 19
CINITAPRIDA COMP. 1 MG. CAJA C/25 HIDROCLOROTIAZIDA 12.50 MG TELMISARTAN 80.00 MG PRINCIPIO ACTIVO: CLONIXINATO DE LISINASUSTANCIA: CINITAPRIDA COMP. 1 MG. CAJA C 25 FABRICANTE: AMSA GENERICO
US$ 152.00
US$ 44.90
US$ 84.00
US$ 44.00